Citigroup’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $52.5M | Sell |
|
|||||
|
2024
Q1 | $80.1M | Buy |
|
|||||
|
2023
Q4 | $21.7M | Buy |
|
|||||
|
2023
Q3 | $1.83M | Buy |
|
|||||
|
2023
Q2 | $2.17M | Sell |
|
|||||
|
2023
Q1 | $4.12M | Buy |
|
|||||
|
2022
Q4 | $3.34M | Sell |
|
|||||
|
2022
Q3 | $3.94M | Buy |
|
|||||
|
2022
Q2 | $2.08M | Buy |
|
|||||
|
2022
Q1 | $725K | Sell |
|
|||||
|
2021
Q4 | $3.96M | Sell |
|
|||||
|
2021
Q3 | $5.8M | Buy |
|
|||||
|
2021
Q2 | $1.67M | Sell |
|
|||||
|
2021
Q1 | $1.43M | Buy |
|
|||||
|
2020
Q4 | $1.52M | Buy |
|